PBA
AUTL
Paradigm Biocapital Advisors’s Autolus Therapeutics AUTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,425,803
| Closed | -$41M | – | 37 |
|
|
2024
Q1 | $41M | Sell |
6,425,803
-6,185,532
| -49% | -$39.5M | 1.44% | 22 |
|
|
2023
Q4 | $81.2M | Sell |
12,611,335
-1,795,447
| -12% | -$11.6M | 3.8% | 13 |
|
|
2023
Q3 | $33.6M | Buy |
14,406,782
+5,189,632
| +56% | +$12.1M | 2.28% | 18 |
|
|
2023
Q2 | $21.9M | Buy |
+9,217,150
| New | +$21.9M | 1.7% | 23 |
|